Quick Answer
China SXT Pharmaceuticals, Inc. reported Shares Outstanding of 13.76 million shares for fiscal year 2025.
China SXT Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 13.76M | +0.0% |
| 2024 | 13.76M | +2909.3% |
| 2023 | 457,365 | -77.5% |
| 2022 | 2.03M | +161.7% |
| 2021 | 776,255 | -91.0% |
| 2020 | 8.67M | -61.8% |
| 2019 | 22.71M | +13.5% |
| 2018 | 20.00M | — |
- China SXT Pharmaceuticals, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, China SXT Pharmaceuticals, Inc.’s shares outstanding has declined by 31.2% (from 20.00 million shares to 13.76 million shares).
- The most recent figure is from China SXT Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: